Remove tag pregnancy
article thumbnail

Grand Rounds October 20, 2023: A National Initiative to Eliminate Hepatitis C in the United States – Why This Matters to Clinical Trialists (Rachael L. Fleurence, PhD, MSc; Joshua M. Sharfstein, MD)

Rethinking Clinical Trials

There are possible clinical research components that would include research on treatment during pregnancy, vaccine development, and implementation model research. The economic benefits of a Hepatitis C elimination program would save lives and have enormous financial benefits to Medicare and Medicaid, paying for the program within 10 years.

article thumbnail

Grand Rounds September 23, 2022: Effect Of An Intensive Nurse Home Visiting Program On Adverse Birth Outcomes In A Medicaid-Eligible Population (Margaret McConnell, PhD)

Rethinking Clinical Trials

The study will be able to follow longer-term outcomes observed following moms and babies for up to 30 years, including health care utilization, timing of subsequent pregnancies, use of social services, criminal justice involvement, educational outcomes and economic opportunity. pctGR, @Collaboratory1.

Nurses 130
article thumbnail

PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS

The Pharma Data

mg) in healthy women ages 18-35 who are at risk for pregnancy. The primary efficacy endpoint is the at-risk Pearl Index, defined as the number of on-treatment pregnancies per 100 women-years of treatment. mg and norethindrone acetate 0.5 Safety data will also be collected during the study. Amy Rose 212.733.7410. Source: Pfizer Inc.